Emerging drugs for idiopathic pulmonary fibrosis

M Selman, A Pardo, L Richeldi… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and usually lethal
lung disorder of unknown etiology. The disease is characterized by alveolar epithelial cell …

The management of patients with idiopathic pulmonary fibrosis

P Spagnolo, A Tzouvelekis, F Bonella - Frontiers in medicine, 2018 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF), the most common form of fibrosing idiopathic interstitial
pneumonia, is an inexorably progressive disease with a 5-year survival of~ 20%. In the last …

Update on therapeutic management of idiopathic pulmonary fibrosis

A Tzouvelekis, F Bonella… - Therapeutics and clinical …, 2015 - Taylor & Francis
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive diffuse parenchymal lung
disease of unknown origin, with a mortality rate exceeding that of many cancers. The …

Advances in the treatment of idiopathic pulmonary fibrosis

A Sergew, KK Brown - Expert Opinion on Emerging Drugs, 2015 - Taylor & Francis
Introduction: Idiopathic pulmonary fibrosis (IPF) is a lung limited, progressive fibrotic disease
with a poor prognosis. The cause is unknown, and currently there is no treatment that …

Evolution and treatment of idiopathic pulmonary fibrosis

SE Torrisi, N Kahn, C Vancheri, M Kreuter - La Presse Médicale, 2020 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic and devastating disease of unknown
etiology, characterized by irreversible morphological changes, ultimately leading to lung …

[HTML][HTML] A review of current and novel therapies for idiopathic pulmonary fibrosis

R Rafii, MM Juarez, TE Albertson… - Journal of thoracic …, 2013 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic interstitial lung disease that is
associated with a median survival of 2-3 years from initial diagnosis. To date, there is no …

Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications

P Spagnolo, G Rossi, A Cavazza - Expert review of clinical …, 2014 - Taylor & Francis
Idiopathic pulmonary fibrosis (IPF) is the most common and lethal form of idiopathic
interstitial pneumonia. The disease is thought to arise following an aberrant reparative …

Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials

S MacIsaac, D Somboonviboon… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating lung disease
with poor prognosis. Although two antifibrotics have been approved in the past decade there …

[PDF][PDF] Idiopathic pulmonary fibrosis: What primary care physicians need to know

LB Tolle, BD Southern, DA Culver, JC Horowitz - Cleve Clin J Med, 2018 - academia.edu
Idiopathic pulmonary fibrosis (IPF) is a specific type of fibrosing interstitial pneumonia of
unknown cause. It is usually chronic and progressive, tends to affect mainly adults over age …

Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?

S Mahendran, T Sethi - QJM: An International Journal of …, 2012 - academic.oup.com
Idiopathic pulmonary fibrosis (IPF) is a progressive age-related lung disease, the cause of
which is not been fully understood. IPF is a devastating disease with mortality worse than …